JP2017536385A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536385A5
JP2017536385A5 JP2017528789A JP2017528789A JP2017536385A5 JP 2017536385 A5 JP2017536385 A5 JP 2017536385A5 JP 2017528789 A JP2017528789 A JP 2017528789A JP 2017528789 A JP2017528789 A JP 2017528789A JP 2017536385 A5 JP2017536385 A5 JP 2017536385A5
Authority
JP
Japan
Prior art keywords
difluorophenyl
piperazin
triazol
tetrahydrofuran
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017528789A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536385A (ja
JP6666345B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2015/053733 external-priority patent/WO2016087880A1/en
Publication of JP2017536385A publication Critical patent/JP2017536385A/ja
Publication of JP2017536385A5 publication Critical patent/JP2017536385A5/ja
Application granted granted Critical
Publication of JP6666345B2 publication Critical patent/JP6666345B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017528789A 2014-12-05 2015-12-04 抗真菌化合物 Active JP6666345B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14196662.2 2014-12-05
EP14196662 2014-12-05
PCT/GB2015/053733 WO2016087880A1 (en) 2014-12-05 2015-12-04 Antimycotic compound

Publications (3)

Publication Number Publication Date
JP2017536385A JP2017536385A (ja) 2017-12-07
JP2017536385A5 true JP2017536385A5 (enExample) 2019-01-31
JP6666345B2 JP6666345B2 (ja) 2020-03-13

Family

ID=52006914

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017528775A Active JP6669751B2 (ja) 2014-12-05 2015-12-04 抗真菌化合物
JP2017528789A Active JP6666345B2 (ja) 2014-12-05 2015-12-04 抗真菌化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017528775A Active JP6669751B2 (ja) 2014-12-05 2015-12-04 抗真菌化合物

Country Status (18)

Country Link
US (12) US10106531B2 (enExample)
EP (2) EP3227278B1 (enExample)
JP (2) JP6669751B2 (enExample)
KR (1) KR102579848B1 (enExample)
CN (2) CN107001343B (enExample)
AU (1) AU2015356795B2 (enExample)
BR (1) BR112017008481B1 (enExample)
CA (1) CA2963625C (enExample)
DK (2) DK3227277T3 (enExample)
EA (1) EA033736B1 (enExample)
ES (2) ES2786374T3 (enExample)
HU (2) HUE048685T2 (enExample)
IL (1) IL251631B (enExample)
MX (1) MX370412B (enExample)
PL (1) PL3227277T3 (enExample)
PT (1) PT3227277T (enExample)
SG (1) SG11201702835RA (enExample)
WO (2) WO2016087878A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3227277T3 (da) 2014-12-05 2020-04-27 Pulmocide Ltd Antimykotisk forbindelse
WO2016097761A1 (en) 2014-12-18 2016-06-23 Pulmocide Limited 4,5-dihydro-6h-thieno[3,2-d]benzazepine derivatives and their use to treat respiratory syncytial virus (rsv) infections
NZ735783A (en) 2015-05-21 2021-12-24 Pulmocide Ltd Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof.
WO2017093491A1 (en) * 2015-12-04 2017-06-08 Pulmocide Limited Antimycotic triazole compound
NZ754205A (en) * 2016-11-28 2022-07-29 Cellix Bio Private Ltd Compositions and methods for the treatment of oral infectious diseases
WO2018115319A2 (en) 2016-12-23 2018-06-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitors of cytochrome p450 family 7 subfamily b member 1 (cyp7b1) for use in treating diseases
GB201917867D0 (en) 2019-12-06 2020-01-22 Pulmocide Ltd Polymorphs
EP3858357A1 (en) * 2020-01-28 2021-08-04 Diaccurate Use of azole compounds to stimulate the immune system and as inhibitors for s-pla2gib
RU2770598C1 (ru) * 2021-06-29 2022-04-18 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" (ПГНИУ) ПРИМЕНЕНИЕ ПРОТИВОГРИБКОВОГО СРЕДСТВА НА ОСНОВЕ 2-((4-R1-5-R2-3-(ЭТОКСИКАРБОНИЛ)ТИОФЕН-2-ИЛ)АМИНО)-4-ОКСО-4-R3-БУТ-2-ЕНОВЫХ КИСЛОТ ПО ОТНОШЕНИЮ К Candida aldicans
WO2025114603A1 (en) 2023-11-30 2025-06-05 Basilea Pharmaceutica International Ag, Allschwil Pharmaceutical combinations for use in the treatment of fungal infections

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533466A (en) * 1978-07-14 1980-03-08 Janssen Pharmaceutica Nv Novel azole derivatives and their manufacture
CH655103A5 (de) * 1983-03-11 1986-03-27 Sandoz Ag Azolderivate, verfahren zu ihrer herstellung und ihre verwendung.
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
DE3609598A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
DE3852477T2 (de) 1987-11-20 1995-05-04 Schering Corp Tri- und tetrasubstituierte Oxetane und Tetrahydrofurane und deren Zwischenprodukte.
US5039678A (en) 1989-03-23 1991-08-13 Wake Forest University Method of increasing cranial vessel proliferation by administering nimodipine
US5039676A (en) 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
US5403937A (en) * 1993-04-30 1995-04-04 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
SK283035B6 (sk) 1993-12-21 2003-02-04 Schering Corporation Tetrahydrofuránová zlúčenina, spôsob jej prípravy, jej farmaceuticky prijateľný ester, soľ a farmaceutický prostriedok
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
PL319635A1 (en) 1995-06-02 1997-08-18 Schering Corp Tetrahydrofurane-based antimycotic agents
EP0957101A1 (en) 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
AU2002257104B2 (en) 2001-04-03 2006-02-09 Merck Sharp & Dohme Corp. Antifungal composition with enhanced bioavailability
JP2011507910A (ja) * 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
US8324385B2 (en) * 2008-10-30 2012-12-04 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
EP2734517B1 (en) * 2011-07-18 2017-08-30 Merck Patent GmbH Benzamides
WO2013036866A1 (en) 2011-09-07 2013-03-14 The Johns Hopkins University Itraconazole analogs and use thereof
DK3227277T3 (da) * 2014-12-05 2020-04-27 Pulmocide Ltd Antimykotisk forbindelse
GB201917867D0 (en) 2019-12-06 2020-01-22 Pulmocide Ltd Polymorphs

Similar Documents

Publication Publication Date Title
JP2017536385A5 (enExample)
JP2017536382A5 (enExample)
RU2501791C2 (ru) Производное триазола или его соль
US6407129B1 (en) Azole compounds, their production and their use
RU2439068C2 (ru) Модуляторы mglur5
JP6666345B2 (ja) 抗真菌化合物
JP2016528201A5 (enExample)
JP2010539188A5 (enExample)
ES2315724T3 (es) Arilpirazoles sustituidos como agentes parasiticidas.
JP2010536767A5 (enExample)
JP2018502906A5 (enExample)
CN106577678A (zh) 含有琥珀酸脱氢酶抑制剂的组合物
CA2338569A1 (en) Method for treating wood against the attack of harmful fungi
JP2009537544A5 (enExample)
JP2017525697A5 (enExample)
JP2004507501A5 (enExample)
JP2013506674A5 (enExample)
RU2015146417A (ru) Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник
RU2006141653A (ru) Доставка противогрибковых лекарственных средств
HRP20250042T1 (hr) Polimorfi triazolnog antifungalnog spoja pc945
CN105745193B (zh) 抗真菌氧代二氢吡啶碳酰肼衍生物
JP2010526051A5 (enExample)
JP2007532654A5 (enExample)
JP2003516975A5 (enExample)
JP2012505226A5 (enExample)